Le Lézard
Classified in: Business
Subject: ATY

ATHENAHEALTH INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of athenahealth, Inc. - ATHN


NEW ORLEANS, Nov. 13, 2018 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of athenahealth, Inc. ("athena") (NasdaqGS: ATHN) to an affiliate of Veritas Capital and Evergreen Coast Capital.  Under the terms of the proposed transaction, shareholders of athena will receive only $135.00 in cash for each share of athena that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Kahn Swick & Foti, LLC ("KSF") - - not all law firms are created equal. Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto/Kahn Swick & Foti, LLC)

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit  https://www.ksfcounsel.com/cases/nasdaqgs-athn/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163

 

SOURCE Kahn Swick & Foti, LLC


These press releases may also interest you

at 04:07
Aker ASA: Presentation of First-Quarter Results 2024
Aker ASA will publish its financial results for the first quarter of 2024 on Wednesday, May 8, 2024, at 07:00 CEST. An online webcast presentation of the results will be available the same day at 09:00 CEST. Webcast details: Date: Wednesday, May 8,...

at 04:00
Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 04:00
Popular uMhlanga Rocks Whalebone Pier in South Africa Gets a New Lease on Life with Penetron Technology
In December 2023, the eThekwini Municipality Mayor, Mxolisi Kaunda, officially reopened the uMhlanga Rocks...

at 03:31
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
BlueFocus (300058.SZ) disclosed its 2023 annual report, revealing a revenue milestone of CN¥52.61 billion (US$7.26 billion), 43.44% growth from the previous year, and a net operating cash flow of CN¥633 million. This achievement positioned BlueFocus...

at 03:30
Eddid ONE and Eddid ONE USA Expand Global Coverage
Eddid Financial ("the Group") announces that its intelligent trading application Eddid ONE and the premier US stock trading application Eddid ONE USA* have expanded their global coverage to 22 countries and regions. The apps are now officially...

at 03:07
HighByte Announces Series A Raise to Accelerate Growth in Industrial DataOps Market
HighByte®, an industrial software company, today announced its Series A funding round led by Standard Investments, a platform investing in innovative growth companies at the intersection of the digital and physical worlds. Standard Investments is...

More news about Business...


News published on and distributed by: